|
Market Closed -
Bombay S.E.
11:02:29 22/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 160.00 INR | +3.46% |
|
+6.74% | -5.94% |
| Market Cap | 509M 5.31M 4.63M 4.36M 3.97M 7.44M 7.45M 52.2M 20.12M 259M 19.94M 19.5M 836M | P/E 2025 |
17.4x | P/E 2026 | 5.8x |
|---|---|---|---|---|---|
| Enterprise Value | 476M 4.97M 4.33M 4.08M 3.72M 6.97M 6.98M 48.88M 18.84M 243M 18.67M 18.25M 783M | EV / Sales 2025 |
2.05x | EV / Sales 2026 | 0.85x |
| Free-Float |
33% | Yield 2025 |
0.87% | Yield 2026 | 1.89% |
| 1 day | +3.46% | ||
| 1 week | +6.74% | ||
| Current month | +2.56% | ||
| 1 month | +4.23% | ||
| 3 months | -10.11% | ||
| 6 months | +47.06% | ||
| Current year | -5.94% |
| 1 week | 147.5 |  | 164.95 |
| 1 month | 143.05 | | 164.95 |
| Current year | 100.1 | | 188 |
| 1 year | 100.1 | | 220 |
| 3 years | 100.1 | | 398 |
| 5 years | 97.4 | | 398 |
| 10 years | 21.5 | | 398 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rajesh Pokerna
CEO | Chief Executive Officer | 61 | 20/08/2016 |
Sunil Kumar Jain
DFI | Director of Finance/CFO | 64 | 06/10/2005 |
| Compliance Officer | - | 02/08/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | 11/12/2005 | |
Sunil Kumar Jain
BRD | Director/Board Member | 64 | 06/10/2005 |
Rajesh Pokerna
BRD | Director/Board Member | 61 | 20/08/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.46% | +6.74% | -16.64% | -16.10% | 5.13M | |
| -1.85% | +2.34% | +54.91% | +111.75% | 1,038B | |
| -1.38% | +1.18% | +52.94% | +66.69% | 649B | |
| -0.79% | +1.04% | +18.88% | +72.38% | 467B | |
| -1.36% | +0.33% | +33.46% | +45.07% | 355B | |
| -0.93% | +2.06% | +18.19% | +26.37% | 269B | |
| -0.53% | +4.06% | +9.63% | +14.14% | 260B | |
| +2.37% | +3.06% | +37.75% | +45.93% | 213B | |
| -1.25% | -6.56% | -32.72% | -59.81% | 176B | |
| -1.11% | +2.83% | +31.97% | +100.03% | 187B | |
| Average | -0.42% | +1.46% | +20.84% | +40.64% | 361.51B | |
| Weighted average by Cap. | -1.25% | +1.47% | +35.33% | +65.79% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 340M 3.55M 3.09M 2.91M 2.65M 4.97M 4.98M 34.89M 13.45M 173M 13.33M 13.03M 559M | 357M 3.73M 3.25M 3.06M 2.79M 5.23M 5.23M 36.67M 14.13M 182M 14.01M 13.7M 587M |
| Net income | 42.46M 443K 386K 364K 331K 621K 622K 4.36M 1.68M 21.63M 1.66M 1.63M 69.8M | 57.89M 604K 527K 496K 452K 847K 848K 5.94M 2.29M 29.49M 2.27M 2.22M 95.16M |
| Net Debt | -36.87M -385K -336K -316K -288K -540K -540K -3.79M -1.46M -18.78M -1.45M -1.41M -60.61M | -32.39M -338K -295K -278K -253K -474K -475K -3.33M -1.28M -16.5M -1.27M -1.24M -53.25M |
Employees
42
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/09/26 | ₹160.00 | +3.46% | 653 |
| 21/09/26 | ₹154.65 | -1.59% | 1,996 |
| 18/09/26 | ₹157.15 | -0.16% | 2,583 |
| 17/09/26 | ₹157.40 | +4.20% | 2,026 |
| 16/09/26 | ₹151.05 | +0.77% | 916 |
- Stock Market
- Stocks
- VRL6 Stock
Select your edition
All financial news and data tailored to specific country editions
